Archives: Antitrust Compliance

Subscribe to Antitrust Compliance RSS Feed

COVID-19 pandemic accelerates the extension of foreign investment control in Germany with regard to transactions in the health care sector

The German Federal Ministry for Economic Affairs and Energy implemented further amendments to the Foreign Trade and Payments Ordinance (Außenwirtschaftsverordnung – AWV) due to the COVID-19 pandemic to prevent the buyout of German companies active in the health care and infection protection sectors by investors from outside the EU (or EFTA). The amendment entered into … Continue Reading

Competition law during the COVID-19 pandemic: several shades freed?

A version of this article was previously published in French by Le Club des Juristes. Following the economic shock caused by the COVID-19 pandemic, the French and European competition authorities announced certain changes to competition law. Companies will be able to cooperate in certain sectors, in particular with a view to promoting the supply, production … Continue Reading

Ninth Circuit’s decision in hiQ Labs, Inc. v. LinkedIn Corp. has major antitrust implications

In hiQ Labs, Inc. v. LinkedIn Corp., No. 17-16783, 2019 WL 4251889 (9th Cir. Sept. 9, 2019), a Ninth Circuit panel affirmed the district court’s grant of a preliminary injunction in favor of hiQ, which prohibited LinkedIn from denying access to publicly available data on LinkedIn profiles. The Ninth Circuit declares that selectively banning potential … Continue Reading

Changes in California could see significant impact on the price of prescription drugs

California Governor Gavin Newsom recently signed an Executive Order to allow state agencies to join together and negotiate the purchase of prescription drugs. This measure could significantly reduce the cost of drugs and therefore will most certainly impact pharmaceutical manufacturers, managed care companies, pharmacies and other industry participants, as well as prescription drug consumers. For … Continue Reading
LexBlog